A CROSS-SECTIONAL STUDY OF FIXED DRUG ERUPTION OF MALE AND FEMALE GENITALIA AT A TERTIARY CARE HOSPITAL OF MIDDLE GUJARAT, INDIA
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i6.47431Keywords:
Genital lesions, Fixed drug eruptions(FDE), Hyperpigmented macular patchesAbstract
Objectives: The point of this study was to introduce a progression of instances of genital lesion with fixed drug eruption, analyze the calprit drug, and distinguish the adjustment of example of medications causing them.
Methods: Finding of fixed drug eruption (FDE) was upheld by a positive history and actual assessment. Information including age, site of lesion, time stretch between drug organization, and FDE improvement was gathered and investigated.
Results: The most widely recognized causative medication was co-trimoxazole in 34 patients (87.17%), trailed by anti-inflammatory medicine in 2 (5.12%) patients, norfloxacin and erythromycin, each utilized by 1 patient (2.56%). A greatest number of patients had lesions on the glans penis (n=30) (76.92%). Hyperpigmented macular lesion were available in 23 patients (58.97%). The most widely recognized side effects which were introduced by the majority of the patients were pruritus (n=29) (74.35%), trailed by a consuming sensation (n=25) (64.10%).
Conclusion: We would like to conclude that co-trimoxazole was the main causative agents of FDE and the most common site was Glans penis in male and in females Vagina and Vulva was the most common site.
Downloads
References
Breathnach SM. Drug reactions. In: Burns T, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. p. 75.28-9.
Revuz J, Allanore LV. Drug reactions. In: Bolognia JL, Jorrizo JL, Schaffer JV, editor. Dermatology. Philadelphia, PA: Elsevier; 2012. p. 345-6.
Baker H. Fixed eruptions. In: Text Book of Dermatology. 3rded. Oxford: Blackwell Scientific Publications; 1979. p. 1121-2.
Shiohara T, Mizukawa Y. Fixed drug eruption: A disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007;17:201-8. doi: 10.1684/ejd.2007.0149, PMID 17478380
Baker H. Fixed Eruptions. Text Book of Dermatology. 3rd ed. Oxford: Blackwell Scientific Publications; 1979. p. 1121-2.
Pasricha JS. Drugs causing fixed eruptions. Br J Dermatol 1979;100:183-85. doi: 10.1111/j.1365-2133.1979.tb05559.x, PMID 154920
Csonka GW, Rosedale N, Walkden L. Balanitis due to fixed drug eruption which are associated with tetracycline therapy. Br J Vener Dis 1971;47:42-4. doi: 10.1136/sti.47.1.42, PMID 4251608
Malhotra S, Pandhi P. Analgesics for pediatric use. Indian J Pediatr 2000;67:589-90. doi: 10.1007/BF02758488, PMID 10985001
Sehgal VN, Srivastava G. Fixed drug eruption (FDE): Changing scenario of incriminating drugs. Int J Dermatol 2006;45:897-908. doi: 10.1111/j.1365-4632.2006.02853.x, PMID 16911371
Kanwar AJ, Kaur S, Thami GP. Nimesulide induced purpura. Dermatology 2000;201:376. doi: 10.1159/000051562, PMID 11146358
Lateo S, Boffa MJ. Localized toxic pustuloderma associated with nimesulide therapy and confirmed by patch testing. Br J Dermatol 2002;147:624-5. doi: 10.1046/j.1365-2133.2002.488512.x, PMID 12207623
Cordeiro MR, Gonçalo M, Fernandes B, Oliveira H, Figueiredo A. Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 2000;43:307. PMID 11016675
Valsecchi R, Reseghetti A, Cainelli T. Bullous and erosive stomatitis induced by nimesulide. Dermatology 1992;185:74-5. doi: 10.1159/000247411, PMID 1638079
Ozkaya-Bayazit E, Bayazit H, Ozarmagan G. Drug related clinical pattern in fixed drug eruption. Eur J Dermatol 2000;10:288-91. PMID 10846256
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr Krunal Tralsawala, DR ARTI BHABHOR, DR RUTU HARSH OZA, DR PRATIK MAKWANA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
